Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-776-4 | CAS number: 308065-15-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- 17 Jun - 01 August 2010
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP guideline study, tested with the source substance CAS 544-35-4. According to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Ethyl linoleate
- EC Number:
- 208-868-4
- EC Name:
- Ethyl linoleate
- Cas Number:
- 544-35-4
- Molecular formula:
- C20H36O2
- IUPAC Name:
- ethyl octadeca-9,12-dienoate
- Details on test material:
- - Name of test material (as cited in study report): ethyl linoleate
- Analytical purity: ca. 100%
- Composition of test material, percentage of components: 75% active substance, 11% octadecenoic acid ethylester (ethyl oleate), 6% hexadecanoic acid ethylester, 3% octadecanoic acid ethylester, 3% octadecadienoic acid glycerol monoester
- Physical state: hazy yellow liquid
- Expiry date: 31 March 2011
Constituent 1
Method
- Target gene:
- not applicable
Species / strain
- Species / strain / cell type:
- primary culture, other: cultured peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI 1640 medium, supplemented with FCS, L-glutamine, pen/strep, heparin
- Properly maintained: yes
- Average Generation time of the cells: 14.3 - 14.5 h
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and ß-naphthoflavone.
- Test concentrations with justification for top dose:
- 1st exp: up to 333 µg/mL (precipitation at 333 µg/mL)
2nd exp: up to 800 µg/mL (precipitation at 333 µg/mL) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: mitomycin C (0.5µg/mL) and cyclophosphamide (10 µg/mL)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
In the first cytogenetic assay, the test substance was tested up to 333 µg/mL for a 3 h exposure time with a 24 h fixation time in the absence and presence of 1.8% (v/v) S9-fraction. Precipitation occurred in the culture medium at this dose level.
In the second cytogenetic assay, the test substance was tested up to 800 µg/mL for a 24 h continuous exposure time with a 24 h fixation time and up to 600 µg/mL for a 48 h continuous exposure time with a 48 h fixation time in the absence of S9-mix. Appropriate toxicity was reached at these dose levels. In the presence of S9-mix the test substance was tested up to 333 µg/mL for a 3 h exposure time with a 48 h fixation time. Precipitation occurred in the culture medium at this dose level.
SPINDLE INHIBITOR: colchicine (0.5 μg/mL medium)
STAIN: 5% (v/v) Giemsa after fixation
NUMBER OF REPLICATIONS: duplicates each in two independent experiments
NUMBER OF CELLS EVALUATED: 200
DETERMINATION OF CYTOTOXICITY
- Method: The mitotic index of each culture was determined by counting the number of metaphases per 1000 cells.
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes
At least three analysable concentrations were used for scoring of the cytogenetic assay. Chromosomes of metaphase spreads were analysed from those cultures with an inhibition of the mitotic index of about 50% or above whereas the mitotic index of the lowest dose level was approximately the same as the mitotic index of the solvent control. Also cultures treated with an intermediate dose were examined for chromosome aberrations. The test substance was difficult to dissolve in aqueous solutions, the highest concentration analysed at the 3 h exposure time was determined by the solubility in the culture medium. If dose related cytotoxicity was observed, the highest concentration analysed at the 24 and 48 h continuous exposure times was based on toxicity irrespective of the solubility of test substance in the culture medium. However, the extent of precipitation may not interfere with the scoring of chromosome aberrations. - Evaluation criteria:
- A test substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations.
b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship. - Statistics:
- The incidence of aberrant cells (cells with one or more chromosome aberrations, gaps included or excluded) for each exposure group outside the laboratory historical control data range was compared to that of the solvent control using Chi-square statistics.
Results and discussion
Test results
- Species / strain:
- primary culture, other: cultured peripheral human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- at 333 µg/mL and above
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: bad water solubility, soluble in dimethyl sulfoxide at concentrations of 33 mg/mL and below but formed a suspension at concentrations of 50 mg/mL and above
- Precipitation: at concentrations of 333 µg/mL and above
RANGE-FINDING/SCREENING STUDIES:
With S9 mix: up to 333 µg/mL for 3 hours. Without S9 mix: up to 1000 µg/mL for 24 and 48 hours (beyond limit of solubility).
No cytotoxicity was observed in the duplicate cultures of the 3 h exposure time and the test substance did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations
COMPARISON WITH HISTORICAL CONTROL DATA:
The number of cells with chromosome aberrations found in the solvent control cultures was within the laboratory historical control data range.
Positive control chemicals, mitomycin C and cyclophosphamide, both produced a statistically significant increase in the incidence of cells with chromosome aberrations, indicating that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly. - Remarks on result:
- other: strain/cell type: lymphocytes
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table1: Chromosome aberrations in human lymphocyte cultures treated with test substance in the absence of S9-mix in the first cytogenetic assay (3 h exposure time, 24 h fixation time)
Conc |
DMSO (1.0% v/v) |
33 µg/mL |
100 µg/mL |
333 µg/mL |
MMC-C 0.5µg/mL |
|||||||||||||||
Culture |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
|||||||||||||||
Mitotic Index (%) |
100 |
104 |
98 |
93 |
76 |
|||||||||||||||
No. of Cells scored |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
50 100 150 |
|||||||||||||||
No. of Cells with aberrations (+ gaps) |
0 |
1 |
1 |
0 |
0 |
0 |
2 |
0 |
2 |
1 |
1 |
2 |
26 |
22 |
***) 48
|
|||||
No. of Cells with aberrations (- gaps) |
0 |
1 |
1 |
0 |
0 |
0 |
2 |
0 |
2 |
1 |
1 |
2 |
26 |
22 |
***) 48
|
|||||
misc. |
|
|
|
|
|
endo |
poly |
endo |
|
|
||||||||||
The numerical variations endoreduplication (endo) and polyploidy (poly) were not counted as an aberration.
*) Significantly different from control group (Chi-square test), * P < 0.05, ** P < 0.01 or *** P < 0.001.
Table2 : Chromosome aberrations in human lymphocyte cultures treated with test substance in the presence of S9-mix in the first cytogenetic assay (3 h exposure time, 24 h fixation time)
Conc Conc |
DMSO (1.0% v/v) |
33 µg/mL |
100 µg/mL |
333 µg/mL |
CP 10µg/mL |
||||||||||
Culture |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
||||||||||
Mitotic Index (%) |
100 |
106 |
101 |
103 |
42 |
||||||||||
No. of Cells scored |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
50 100 150 |
||||||||||
No. of Cells with aberrations (+ gaps) |
1 |
0 |
1 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
2 |
27 |
16 |
***) 43
|
No. of Cells with aberrations (- gaps) |
1 |
0 |
1 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
2 |
27 |
16 |
***) 43
|
Table3: Chromosome aberrations in human lymphocyte cultures treated with test substance in the absence of S9-mix in the second cytogenetic assay (24 h exposure time, 24 h fixation time)
Conc |
DMSO (1.0% v/v) |
100 µg/mL |
600 µg/mL |
800 µg/mL |
MMC-C 0.2µg/mL |
||||||||||
Culture |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
||||||||||
Mitotic Index (%) |
100 |
102 |
85 |
35 |
53 |
||||||||||
No. of Cells scored |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
||||||||||
No. of Cells with aberrations (+ gaps) |
1 |
1 |
2 |
0 |
1 |
1 |
0 |
2 |
2 |
1 |
0 |
1 |
29 |
30 |
***) 59
|
No. of Cells with aberrations (- gaps) |
1 |
1 |
2 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
1 |
29 |
29 |
***) 58
|
Table4 : Chromosome aberrations in human lymphocyte cultures treated with test substance in the absence of S9-mix in the second cytogenetic assay (48 h exposure time, 48 h fixation time)
Conc |
DMSO (1.0% v/v) |
100 µg/mL |
500 µg/mL |
600 µg/mL |
MMC-C 0.1µg/mL |
||||||||||
Culture |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
||||||||||
Mitotic Index (%) |
100 |
99 |
60 |
49 |
77 |
||||||||||
No. of Cells scored |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
50 100 150 |
||||||||||
No. of Cells with aberrations (+ gaps) |
1 |
1 |
2 |
1 |
1 |
2 |
4 |
1 |
5 |
1 |
2 |
3 |
25 |
31 |
***) 56
|
No. of Cells with aberrations (- gaps) |
1 |
0 |
1 |
1 |
1 |
2 |
3 |
1 |
4 |
1 |
1 |
2 |
25 |
28 |
***) 53
|
Table5: Chromosome aberrations in human lymphocyte cultures treated with test substance in the presence of S9-mix in the second cytogenetic assay (3 h exposure time, 48 h fixation time)
Conc |
DMSO (1.0% v/v) |
33 µg/mL |
100 µg/mL |
333 µg/mL |
CP 10µg/mL |
||||||||||
Culture |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
A B A+B |
||||||||||
Mitotic Index (%) |
100 |
101 |
107 |
103 |
-a |
||||||||||
No. of Cells scored |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
100 100 200 |
||||||||||
No. of Cells with aberrations (+ gaps) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
1 |
33 |
29 |
***) 62
|
No. of Cells with aberrations (- gaps) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
33 |
29 |
***) 62
|
aCP was fixed after 24 hours. Therefore, the mitotic index could not be calculated as percentage of control.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
